Free shipping on all orders over $79* Limited Time Only
Track My Order
Help Centre
Likes
My Wish ListsLogin / Join
Booktopia
Australia's local bookstore
Get Free Shipping on orders over $79
Pharmaceutical Biocatalysis : Important Enzymes, Novel Targets, and Therapies - Peter Grunwald

Pharmaceutical Biocatalysis

Important Enzymes, Novel Targets, and Therapies

By: Peter Grunwald

eText | 1 November 2020 | Edition Number 1

At a Glance

eText

$402.60

or 4 interest-free payments of $100.65 with

 or 

Instant online reading in your Booktopia eTextbook Library *

Why choose an eTextbook?

Instant Access *

Purchase and read your book immediately

Read Aloud

Listen and follow along as Bookshelf reads to you

Study Tools

Built-in study tools like highlights and more

* eTextbooks are not downloadable to your eReader or an app and can be accessed via web browsers only. You must be connected to the internet and have no technical issues with your device or browser that could prevent the eTextbook from operating.

This volume of Pharmaceutical Biocatalysis starts with a discussion on the importance of biocatalytic synthesis approaches for a sustainable and environmentally friendly production of pharmaceuticals and active pharmaceutical ingredients. Among the enzymes discussed in detail with respect to their pharmaceutical relevance are cyclic nucleotide phosphodiesterases playing an important role in modulating signal transduction in various cell types; human DOPA decarboxylase, related to Parkinson's disease and aromatic amino acid decarboxylase deficiency; and phospholipase D enzymes as drug targets. Isocitrate dehydrogenase 1 and 2 mutations are novel therapeutic targets in acute myeloid leukemia. An additional chapter is devoted to the use of enzymes for prodrug activation in cancer therapy. The other topics include small-molecule inhibitors targeting receptor tyrosine kinases in cancer, ?-Lactams and related compounds as antibacterials, non-vitamin K oral anticoagulants for the treatment of thromboembolic diseases, and the molecular mechanisms for statin pleiotropy and its clinical relevance in cardiovascular diseases. The last chapter is a review of lysosomal storage disorders with an overview of approved drugs for treating these disorders by enzyme replacement therapy.

on
Desktop
Tablet
Mobile

You Can Find This eBook In

Non-FictionMedicineNursing & Ancillary ServicesPharmacy & DispensingEngineering & TechnologyBiochemical EngineeringBiotechnologyScienceChemistryIndustrial Chemistry & Manufacturing TechnologiesIndustrial ChemistryPharmaceutical Technology
Pre-Clinical Medicine & Basic SciencesBiology, Life SciencesEnvironmental ScienceChemical Engineering

More in Pharmacy & Dispensing

Biochemistry - Raymond S Ochs

eTEXT

Biochemistry

eText

$218.99

This product is categorised by